VRS
MRNA icon

Virginia Retirement Systems’s Moderna MRNA Stock Holding History

Virginia Retirement Systems’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.44M Buy
63,350
+18,500
+41% +$957K 0.03% 334
2026
Q1 		$2.28M Sell
44,850
-15,300
-25% -$714K 0.02% 408
2025
Q4 		$1.77M Buy
60,150
+23,550
+64% +$640K 0.01% 449
2025
Q3 		$945K Buy
36,600
+13,500
+58% +$377K 0.01% 610
2025
Q2 		$637K Buy
+23,100
New +$608K ﹤0.01% 701
2023
Q3 		– Sell
-77,002
Closed -$9.36M – 1000
2023
Q2 		$9.36M Sell
77,002
-107,000
-58% -$14.3M 0.09% 206
2023
Q1 		$28.3M Buy
184,002
+117,102
+175% +$19.3M 0.29% 110
2022
Q4 		$12M Sell
66,900
-33,600
-33% -$5.49M 0.13% 199
2022
Q3 		$11.9M Buy
+100,500
New +$15.2M 0.13% 177
2022
Q1 		$10.6M Buy
61,700
+32,500
+111% +$5.47M 0.1% 223
2021
Q4 		$7.42M Hold
29,200
– – 0.05% 264
2021
Q3 		$11.2M Sell
29,200
-12,300
-30% -$4.54M 0.12% 203
2021
Q2 		$9.75M Sell
41,500
-4,900
-11% -$876K 0.1% 225
2021
Q1 		$6.08M Buy
46,400
+800
+2% +$116K 0.06% 288
2020
Q4 		$4.76M Buy
+45,600
New +$4.61M 0.05% 289

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Virginia Retirement Systems's MRNA Position: Q2 2026 in Review

Virginia Retirement Systems increased its Moderna (MRNA) stake by 41% in Q2 2026, buying an estimated $957K and bringing the position to 63,350 shares worth $4.44M. The position accounts for 0.03% of the portfolio, ranked #334.

Virginia Retirement Systems first reported a position in MRNA in Q4 2020 and has held it in 15 quarters since. The position peaked at $28.3M in Q1 2023. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Virginia Retirement Systems held 63,350 shares of Moderna worth $4.44M as of Q2 2026.
  • Virginia Retirement Systems bought 18,500 Moderna shares in Q2 2026, an estimated $957K.
  • Moderna made up 0.03% of Virginia Retirement Systems's portfolio in Q2 2026, its #334 holding.
  • Virginia Retirement Systems first reported a position in Moderna in Q4 2020 and has held it in 15 quarters since.
  • Virginia Retirement Systems's Moderna position peaked at $28.3M in Q1 2023.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.